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of department for a positive reference. A
“breach of appropriate authorship,” which
is an understatement, can be expected.
Possible signs for this breach could be
as follows:
● More than 4 or 5 authors (if it is not
a multicenter study)
● Authors whose names appear annu-
ally in more than 4 full articles
These signs, however, can depend on
the type of research and local organization
of the research group.
If these signs become apparent, a deep
inquiry by the editor might be warranted.
An alternative is to limit the number of
authors. If acknowlegdements are more de-
tailed and, what is most important, valued
by the supporting universities, the incen-
tive for a breach of appropriate authorship
might disappear or at least diminish.
Wilhelm P. Mistiaen, MSc, MD, PhD
The University College of Antwerp
Dept of Healthcare Sciences
Antwerp, Belgium
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Reply to the Editor:
Thanks to Dr Mistiaen for well-focused
questions and comments. They will help
move the guidelines in the consensus state-
ment closer to implementation in practice. I
will try to answer them in practical terms.
1. How will the statement be imple-
mented? By absorption into custom-
ary best practice, like the general
compliance with our other Instruc-
tions to Authors about manuscript
preparation, graphics, and refer-
ences. Despite variations, compli-
ance will steadily and iteratively im-
prove.
2. Can one rely on honesty of the co-
authors? Generally, yes. Honesty is
a dominant value, and trust is the
basis for most discourse in society
and in science. Untrustworthy be-
havior is eventually exposed by
peers, damaging reputations and re-
ducing the level of respect in the
community of scientists and sur-
geons.
3. Is a simple statement of the authors’
contributions to the paper sufficient?
Yes; explanations can be simple and
clear, that is, as described in a recent
editorial: “[Dr Author] was the pri-
mary author and was responsible for
the design of the study and the anal-
ysis and interpretation of the data.
[Dr Data] supervised the develop-
ment of the database, provided input
on the study design, and reviewed
and approved the final manuscript.
[Dr Investigator] was the principal
investigator of the study, supervised
the acquisition and interpretation of
the data, and provided critical input
to the manuscript.”1
4. Isn’t the grim reality that many uni-
versities require us to “publish or
perish” an obstacle to honesty? Pro-
motion policies based on publication
quantity have resulted in dilute re-
sumes and an unsustainable multipli-
cation of specialized journals.2 Best
practices for assessing scholarship are
emerging and displacing unreflective
quantitative measurement of pub-
lished work, though progress is
slow. In a recent issue of Nature
Medicine largely devoted to exposi-
tion and extension of her seminal
work, Karen Ashe,3 a world leader
in Alzheimer research, recounts
how she was promoted and sup-
ported by the University of Minne-
sota through three unpublished
years as she developed her trans-
genic mouse model of the disease.
The promotions committee of the
University of Toronto Department
of Surgery assigns little weight to
publications that reflect ancillary
authorship. Careers in departments
that rely on publication volume
alone for promotion are impover-
ished academic opportunities. The
chair who insists on authorship in ex-
change for resources, support, or let-
ters of reference will become an
anachronism if accurate description of
the role of authors becomes part of the
culture of surgical publication.
The ethics of authorship1 is a guide to
what we should do on the basis of princi-
ples and values. Journal policy is a state-
ment of what a reasonable group of repre-
sentatives of the Association decide to
adopt as standard practice for the organiza-
tion’s publications. Such decisions should
be made with criteria of reasonableness,
transparency, appealability, and enforce-
ability.4 I think the Journal’s decision to
adopt the consensus statement meets this
standard, but the last criterion is where Dr
Mistiaen’s challenge finds the weakest
point in the consensus statement as pol-
icy. The Journal can only encourage, and
reinforce by occasional challenges or
commentary, an authorship policy that
depends primarily on the authors for im-
plementation.
Dr Mistiaen, I am in favor of adopting the
consensus statement as policy because it
helps strengthen the authenticity and integ-
rity of medical publication. Rather than an
absolute limit on the number of authors, I
favor your suggestion of deep and thought-
ful inquiry by the editor to clarify or justify
the number of authors. Inquiries from re-
spected colleagues in our specialty have a
salutary effect on practice and behavior. To
implement your suggestion, I will enjoy
passing this responsibility along to Editor
Wechsler in his leadership role on the Jour-
nal.
Thank you for your insights and thought-
ful suggestions.
Martin McKneally, MD
Department of Surgery
University of Toronto
Toronto, Ontario, Canada
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Extracorporeal life support: An
effective and noninvasive way to
treat acute necrotizing eosinophilic
myocarditis
To the Editor:
We read with great interest the case report
of Kohout and colleagues1 describing the
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successful management of acute necrotiz-
ing eosinophilic myocarditis (ANEM) with
a biventricular assist device (BIVAD) and
steroids.
ANEM is indeed a dramatic condition
often leading to a fatal issue unless promptly
managed with circulatory support and steroid
administration.2 Endomyocardial biopsy is
essential to diagnosis confirmation and rapid
therapeutic choice making.
The particularity of ANEM is rapid and
spectacular circulatory improvement when
steroids are administered early enough.2
Therefore, we think that a BIVAD is prob-
ably too aggressive and that a far less-
invasive mean, such as extracorporeal life
support (ECLS), is more appropriate for
such a condition.
One month ago, we had a case similar to
that described by Kohout and colleagues.1
A 19-year-old woman presented to our de-
partment with abrupt onset of congestive
heart failure and respiratory distress. She
had been already intubated before admis-
sion, and echocardiography showed a much
altered heart function, with moderately di-
lated left and right ventricles, and a left
ventricular ejection fraction of less then 10%.
Computed tomography scan ruled out pul-
monary embolism and confirmed severe pul-
monary edema. The girl had an unremark-
able medical history, with no proof of drug
abuse or medications. She had no other
symptoms suggesting a preexisting disor-
der except for mild abdominal pain 1 day
earlier. Blood examination results showed
no particularity. Serologic and polymerase
chain reaction screening results for viral or
other infectious diseases returned to normal
later on.
In this context of severe congestive heart
failure, a femoro-femoral ECLS was insti-
tuted in the special care unit at the patient’s
bedside, with a blood output of 3.5 L/mn.
Inotropic support with norepinephrine and
dobutamine was also started. Adequate un-
loading of the left and right-sided heart
chambers was assessed with a Swan–Ganz
catheter and echocardiography.
On day 1, chest radiography showed a
great reduction of the pulmonary edema
(Figure 1). An endomyocardial biopsy was
performed, which confirmed the diagnosis
of ANEM on day 2. Steroids were imme-
diately begun. The improvement was spe-
tacular. As soon as day 6, echocardiogra-
phy showed marked improvement of the
cardiac function. Weaning from ECLS was
begun on day 7 and removed on day 10.
Cardiac echocardiography showed a com-
pletely normalized left ventricular func-
tion. The patient was discharged from the
special care unit on day 13.
When ANEM is suspected, we think
that ECLS is an excellent device for first-
line circulatory support. Prompt endomyo-
cardial biopsy is mandatory to confirm the
diagnosis and initiate intravenous steroids.
This offers the advantage of avoiding the
primary use of a far more aggressive mean
of circulatory support, such as a BIVAD, in
a condition that is likely to respond rapidly
and favorably to steroids. In case the bi-
opsy rules out ANEM, then ECLS, if in-
sufficient, could be removed, and other
more aggressive means of circulatory sup-
port instituted.3
Ziad Khabbaz, MD
Jean-Michel Grinda, MD
Jean-Noël Fabiani, MD
The Université René Descartes
AP-HP, Service de
Chirurgie Cardio-Vasculaire
Hôpital Européen Georges Pompidou
Paris, France
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Reply to the Editor:
We thank Dr Khabbaz and colleagues for
their contribution to the management of
acute necrotizing eosinophilic myocarditis
with mechanical circulatory assist. In our
article,1 we make no attempt to suggest that
ventricular assist device (VAD) support is
the only method by which to properly man-
age the disease. On the contrary, we rec-
ognize the fact that this is a life-threatening
disorder on the one hand, but responsive to
steroid therapy on the other. Treatment
strategies have ranged from steroid therapy
alone2 to transplantation.3 The main mes-
sage in our article and others is to support
the circulation while the diagnosis is made
and treatment is initiated. The precise
method by which to accomplish these ends
varies according to the condition of the
patient at the time of presentation, the tools
and technologies available at the treating
Figure 1. Chest x-ray film before ECLS (left). It was done on the admission of the patient
and shows bilateral pulmonary edema and heart enlargement, with a cardiothoracic index
of 0.60. Chest x-ray film 1 day after ECLS institution (right). Pulmonary edema is already
greatly reduced, and cardiothoracic index decreased to 0.45.
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